(Q46963345)

English

Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

author name string

P L J van der Heiden

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

J S Kalpoe

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

R M Barge

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

R Willemze

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

A C M Kroes

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

E F Schippers

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

37

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

693-698

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705311

0 references

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Beta-herpesvirus challenges in the transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Pre-emptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

21 January 2018

Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705311

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705311

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501590

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46963345&oldid=2139776072"